A prognosis model for clear cell renal cell carcinoma based on four necroptosis-related genes

被引:3
作者
Qiu, Qiangmin [1 ]
Li, Yanze [1 ]
Zhang, Ye [1 ]
Hou, Yanguang [1 ]
Hu, Juncheng [1 ,2 ]
Wang, Lei [1 ]
Chen, Zhiyuan [1 ]
Lei, Yourong [3 ]
Du, Yang [1 ]
Liu, Xiuheng [1 ]
机构
[1] Wuhan Univ, Dept Urol, Renmin Hosp, Wuhan, Peoples R China
[2] Wuhan Univ, Inst Urol Dis, Renmin Hosp, Wuhan, Peoples R China
[3] Wuhan Univ, Dept Infect Prevent & Control, Renmin Hosp, Wuhan, Peoples R China
关键词
necroptosis; clear cell renal cell carcinoma; prognosis; platinum drug resistance; genes;
D O I
10.3389/fmed.2022.942991
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Necroptosis is a type of caspase-independent cell death, and it plays a critical role in regulating the development of cancer. To date, little is known about the role of necroptosis-related genes (NRGs) in clear cell renal cell carcinoma (ccRCC). In this study, we downloaded data regarding the expression of NRGs and overall survival (OS) from The Cancer Genome Atlas (TCGA) database and constructed a risk model to determine the prognostic features of necroptosis using COX regression analysis. Patients with ccRCC were divided into low-risk and high-risk groups based on their risk scores. Thereafter, Kaplan-Meier curves were used to evaluate OS, and receiver operating characteristic (ROC) curves were used to determine the accuracy of prediction. Stratified analyses were performed according to different clinical variables. Furthermore, we assessed the correlation between clinical variables and risk scores; the NRGs with differential expression were mainly enriched in positive regulation of intracellular transport and platinum resistance pathways. We constructed prognostic signatures for OS based on four NRGs and showed that the survival time was significantly longer in the low-risk groups than in the high-risk groups (p < 0.001). The area of the ROC curve for OS was 0.717, indicating excellent predictive accuracy of the established model. Therefore, a predictive model based on NRGs was constructed, which can predict the prognosis of patients and provides insights into the biological mechanisms underlying necroptosis in patients with ccRCC.
引用
收藏
页数:12
相关论文
共 28 条
  • [1] Tubular epithelial cells in renal clear cell carcinoma express high RIPK1/3 and show increased susceptibility to TNF receptor 1-induced necroptosis
    Al-Lamki, R. S.
    Lu, W.
    Manalo, P.
    Wang, J.
    Warren, A. Y.
    Tolkovsky, A. M.
    Pober, J. S.
    Bradley, J. R.
    [J]. CELL DEATH & DISEASE, 2016, 7 : e2287 - e2287
  • [2] Landscape of immune cell infiltration in clear cell renal cell carcinoma to aid immunotherapy
    Bai, Dan
    Feng, Huhu
    Yang, Jiajun
    Yin, Aiping
    Qian, Airong
    Sugiyama, Hiroshi
    [J]. CANCER SCIENCE, 2021, 112 (06) : 2126 - 2139
  • [3] The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death
    Burton, T. R.
    Gibson, S. B.
    [J]. CELL DEATH AND DIFFERENTIATION, 2009, 16 (04) : 515 - 523
  • [4] Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma
    Dufies, Maeva
    Verbiest, Annelies
    Cooley, Lindsay S.
    Ndiaye, Papa Diogop
    He, Xingkang
    Nottet, Nicolas
    Souleyreau, Wilfried
    Hagege, Anais
    Torrino, Stephanie
    Parola, Julien
    Giuliano, Sandy
    Borchiellini, Delphine
    Schiappa, Renaud
    Mograbi, Baharia
    Zucman-Rossi, Jessica
    Bensalah, Karim
    Ravaud, Alain
    Auberger, Patrick
    Bikfalvi, Andreas
    Chamorey, Emmanuel
    Rioux-Leclercq, Nathalie
    Mazure, Nathalie M.
    Beuselinck, Benoit
    Cao, Yihai
    Bernhard, Jean Christophe
    Ambrosetti, Damien
    Pages, Gilles
    [J]. COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [5] A Clearer View of the Molecular Complexity of Clear Cell Renal Cell Carcinoma
    Frew, Ian J.
    Moch, Holger
    [J]. ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10, 2015, 10 : 263 - 289
  • [6] PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3
    Gao, Zhipeng
    Man, Xiaojun
    Li, Zhenhua
    Bi, Jianbin
    Liu, Xiankui
    Li, Zeliang
    Li, Jun
    Zhang, Zhe
    Kong, Chuize
    [J]. CANCER GENE THERAPY, 2020, 27 (06) : 412 - 423
  • [7] The role of necroptosis in cancer biology and therapy
    Gong, Yitao
    Fan, Zhiyao
    Luo, Guopei
    Yang, Chao
    Huang, Qiuyi
    Fan, Kun
    Cheng, He
    Jin, Kaizhou
    Ni, Quanxing
    YU, Xianjun
    Liu, Chen
    [J]. MOLECULAR CANCER, 2019, 18 (1)
  • [8] Current State of Systemic Therapies for Advanced Renal Cell Carcinoma
    Gulati, Shuchi
    Vaishampayan, Ulka
    [J]. CURRENT ONCOLOGY REPORTS, 2020, 22 (03)
  • [9] RIP3-mediated necroptosis is regulated by inter-filament assembly of RIP homotypic interaction motif
    Hu, Hong
    Wu, Xialian
    Wu, Guoxiang
    Nan, Ning
    Zhang, Jing
    Zhu, Xinxin
    Zhang, Yu
    Shu, Zhaoqian
    Liu, Jia
    Liu, Xiaoyan
    Lu, Junxia
    Wang, Huayi
    [J]. CELL DEATH AND DIFFERENTIATION, 2021, 28 (01) : 251 - 266
  • [10] CD40 induces renal cell carcinoma-specific differential regulation of TRAF proteins, ASK1 activation and JNK/p38-mediated, ROS-dependent mitochondrial apoptosis
    Ibraheem, Khalidah
    Yhmed, Albashir M. A.
    Qayyum, Tahir
    Bryan, Nicolas P.
    Georgopoulos, Nikolaos T.
    [J]. CELL DEATH DISCOVERY, 2019, 5 (1)